{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:25:32Z","timestamp":1770719132297,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,9]]},"DOI":"10.7759\/cureus.103286","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:49:04Z","timestamp":1770652144000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Ischemic Stroke as the Initial Manifestation of Antiphospholipid Syndrome After SARS-CoV-2 Infection in a 17-Year-Old Patient"],"prefix":"10.7759","author":[{"given":"Carlos A","family":"Portales Cameras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio E","family":"Rodr\u00edguez Vergara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A","family":"G\u00f3mez N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E","family":"C\u00f3rdova Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Cervantes-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268481","article-title":"Causes of ischemic stroke in young adults versus non-young adults: a multicenter hospital-based observational study","volume":"17","author":"Ohya Y","year":"2022","unstructured":"Ohya Y, Matsuo R, Sato N, et al.. Causes of ischemic stroke in young adults versus non-young adults: a multicenter hospital-based observational study. PLoS One. 2022, 17:e0268481. 10.1371\/journal.pone.0268481","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/17474930221150349","article-title":"Antiphospholipid syndrome, antiphospholipid antibodies, and stroke","volume":"18","author":"Mittal P","year":"2023","unstructured":"Mittal P, Quattrocchi G, Tohidi-Esfahani I, Sayar Z, Chandratheva A, Cohen H. Antiphospholipid syndrome, antiphospholipid antibodies, and stroke. Int J Stroke. 2023, 18:383-91. 10.1177\/17474930221150349","journal-title":"Int J Stroke"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030733","article-title":"Antiphospholipid syndrome: a comprehensive clinical review","volume":"14","author":"Patriarcheas V","year":"2025","unstructured":"Patriarcheas V, Tsamos G, Vasdeki D, et al.. Antiphospholipid syndrome: a comprehensive clinical review. J Clin Med. 2025, 14:4-6. 10.3390\/jcm14030733","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211002274","article-title":"Ischemic stroke in the young","volume":"27","author":"Berkman SA","year":"2021","unstructured":"Berkman SA, Song SS. Ischemic stroke in the young. Clin Appl Thromb Hemost. 2021, 27:10760296211002274. 10.1177\/10760296211002274","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni PL","year":"2011","unstructured":"Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011, 7:330-9. 10.1038\/nrrheum.2011.52","journal-title":"Nat Rev Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.33590\/emjrheumatol\/10312311","article-title":"Antiphospholipid syndrome novel therapies","volume":"4","author":"Bittar M","year":"2014","unstructured":"Bittar M, Uthman I. Antiphospholipid syndrome novel therapies. Eur Med J Rheumatol. 2014, 4:113-21. 10.33590\/emjrheumatol\/10312311","journal-title":"Eur Med J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1776910","article-title":"Risk factors for antiphospholipid antibodies and antiphospholipid syndrome","volume":"50","author":"Aguirre Del-Pino R","year":"2024","unstructured":"Aguirre Del-Pino R, Monahan RC, Huizinga TW, Eikenboom J, Steup-Beekman GM. Risk factors for antiphospholipid antibodies and antiphospholipid syndrome. Semin Thromb Hemost. 2024, 50:817-28. 10.1055\/s-0043-1776910","journal-title":"Semin Thromb Hemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13379","article-title":"IgG\/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis","volume":"14","author":"Kelchtermans H","year":"2016","unstructured":"Kelchtermans H, Pelkmans L, de Laat B, Devreese KM. IgG\/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis. J Thromb Haemost. 2016, 14:1530-48. 10.1111\/jth.13379","journal-title":"J Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020516","article-title":"The new occurrence of antiphospholipid syndrome in severe COVID-19 cases with pneumonia and vascular thrombosis could explain the post-COVID syndrome","volume":"13","author":"Zlatkovi\u0107-\u0160venda M","year":"2025","unstructured":"Zlatkovi\u0107-\u0160venda M, Ra\u0161i\u0107 M, Ovuka M, et al.. The new occurrence of antiphospholipid syndrome in severe COVID-19 cases with pneumonia and vascular thrombosis could explain the post-COVID syndrome. Biomedicines. 2025, 13:4-6. 10.3390\/biomedicines13020516","journal-title":"Biomedicines"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya M","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, et al.. 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023, 82:1258-70. 10.1136\/ard-2023-224609","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/459122-acute-ischemic-stroke-as-the-initial-manifestation-of-antiphospholipid-syndrome-after-sars-cov-2-infection-in-a-17-year-old-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:49:05Z","timestamp":1770652145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/459122-acute-ischemic-stroke-as-the-initial-manifestation-of-antiphospholipid-syndrome-after-sars-cov-2-infection-in-a-17-year-old-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.103286","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,9]]}}}